CTS (CTS) director reports 3,500-share award; owns 35,913
CTS Corp (CTS) disclosed a director equity award on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CTS Corp (CTS) disclosed a director equity award on a Form 4. On 11/06/2025, a director acquired 3,500 shares of common stock at $0 (coded “A”). Following the transaction, the director beneficially owns 35,913 shares, held directly.
The filing notes these were restricted stock units that vest 100% on the first anniversary of the grant date, contingent on continued service as a director through the vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CTS (CTS) report?
What is the vesting schedule for the new CTS award?
What does transaction code 'A' indicate in this CTS filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.